Drug intelligence / Profile preview

mm-miR-378a-3p mimic

Development stage
Preclinical
Lead developer
UVEG
Modality
RNA Therapeutics → Nucleic Acid Therapeutics
Administration
Intravenous
01

Overview

mm-miR-378a-3p mimic is a synthetic double-stranded RNA designed to replicate the biological activity of the endogenous mouse microRNA miR-378a-3p. In preclinical research, specifically in murine models of intestinal fibrosis (such as the DSS-induced model), the administration of this mimic has been shown to exacerbate chronic inflammation and fibrotic progression. Despite miR-378a-3p levels being naturally reduced in fibrotic colonic tissue, exogenous replacement via intravenous injection leads to increased neutrophil infiltration, architectural distortion of the glandular epithelia, and elevated expression of pro-fibrotic and pro-inflammatory markers, including Tgfb1, Il1b, and Mmp2. In human intestinal fibroblasts, the human ortholog (hsa-miR-378a-3p) has been observed to upregulate the anti-apoptotic molecules BCL2 and MCL1, potentially contributing to fibroblast persistence in chronic disease states.

Other names
miR-378a-3p mimicmiR378a-3p mimicmiR 378a-3p mimicmouse miR-378a-3p mimic
02

Targets

Interleukin-1 beta (IL1B) mRNA 3' untranslated regionMCL1 (Myeloid cell leukemia sequence 1)MMP2 (Matrix metalloproteinase-2)

Beyond the preview

Go deeper on mm-miR-378a-3p mimic.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on mm-miR-378a-3p mimic.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call